Menu ×

HEALTHCARE & PHARMACEUTICAL

Liposome Drug Delivery Market Segmentation by Product (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, and Others); by Technology (Stealth, Non-PEGylated, and DepoFoam Liposome Technology); and by Application (Fungal Diseases, Pain Management, Cancer Therapy, Viral Vaccines, Photodynamic Therapy, and Others) – Global Demand Analysis & Opportunity Outlook 2021-2031

  • Text Size:

Extensive insights into the Growth of Liposome Drug Delivery Market amidst COVID-19

Get the detailed impact analysis of COVID-19 that has disrupted the entire world and affected many industries.

Request Insights


IN THE NEWS

  • December 9th, 2019: FUJIFILM Toyama Chemical Co., Ltd. announced that it has completed its first manufacturing facility named 701 for liposome formulation in Japan.

  • June 17th, 2020: Ipsen Pharma announced that it has received the Fast Track designation by the United States Food and Drug Administration (FDA) for the investigational use of liposomal irinotecan (ONIVYDE) in combination with oxaliplatin (OX) and 5-fluorouracil/leucovorin (5-FU/LV) together.

Global Liposome Drug Delivery Market Highlights Over 2021 - 2031

The global liposome drug delivery market is estimated to garner a revenue of USD 11977.1 Million by the end of 2031 by growing at a CAGR of 10.69% over the forecast period, i.e., 2022 – 2031. Moreover, in the year 2021, the market generated a revenue of USD 4356.7 Million. The growth of the market can be attributed to the rising prevalence of cancer, and therefore the need for advanced drug delivery systems for the treatment of the disease. Cancer is known to be one of the leading causes of death around the globe according to the World Health Organization (WHO). Moreover, the WHO also stated that in the year 2020, nearly 10 Million deaths were caused as a result of cancer. With several research and development activities happening worldwide for the development of drugs and drug delivery devices for the treatment of cancer, liposomes have been shown to be particularly beneficial in the treatment of the chronic disease. Liposomes, which are a novel drug delivery system (NDDS), are known to reduce the harmful effects of chemotherapeutic drugs. On the other hand, the rising focus of the healthcare researchers on developing targeted drug delivery systems (TDDS) is also expected to create numerous opportunities for market growth. Besides this, the surge in use of liposomes as a drug delivery system is also expected to contribute to the growth of the market during the forecast period.

Liposome Drug Delivery Market Graph

Get more information on this report: Request Sample PDF

Global Liposome Drug Delivery Market Regional Synopsis

Regionally, the global liposome drug delivery market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America is projected to garner the largest revenue of USD 4429.6 Million by the end of 2031, up from a revenue of USD 1689.9 Million in the year 2021. The growth of the market in the region can primarily be attributed to the increasing prevalence of cancer in the region, followed by the surge in government initiatives that promote research and development for cancer drugs and drug delivery systems, along with the surge in healthcare expenditure in the region. According to the statistics by the National Cancer Institute (NCI), in the year 2020, the new cases of cancer that was expected to be diagnosed in the United States was about 1806590 cases. The statistics also stated that during the same year 606520 people were expected to die as a result of the disease.

On the other hand, the market in Europe is projected to garner the second-largest revenue of USD 4213.1 Million by the end of 2031, up from a revenue of USD 1500.9 Million in the year 2021. The market in the region is further segmented by country into Germany, France, United Kingdom, Italy, Spain, and the Rest of Europe. The market in Germany is projected to garner the second-largest revenue of USD 828.4 Million by the end of 2031, up from a revenue of USD 276.2 Million in the year 2021.

The study further incorporates Y-O-Y Growth, market opportunities, demand & supply and forecast future opportunity in North America (United States, Canada, Mexico), South America, Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX [Belgium, Netherlands, Luxembourg], NORDIC [Norway, Denmark, Sweden, Finland], Poland, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa).

Growth Drivers and Challenges Impacting the Growth of the Global Liposome Drug Delivery Market

Growth Drivers

  • Rising Prevalence of Cancer Globally
  • Increasing Application of Liposomes as a Drug Delivery System

Challenges

  • High Cost of Development of the Drug Delivery System

Global Liposome Drug Delivery Market Segmentation Synopsis

The global liposome drug delivery market is segmented by product into liposomal doxorubicin, liposomal paclitaxel, liposomal amphotericin B, and others. The liposomal doxorubicin segment is projected to garner the largest revenue of USD 3218.1 Million by the end of 2031, up from a revenue of USD 1142.1 Million in the year 2021. By technology, the market is segmented by technology into stealth liposome technology, non-PEGylated liposome technology, and DepoFoam liposome technology. Out of these, the stealth liposome technology segment is projected to garner the largest revenue of USD 5181.3 Million by the end of 2031, up from a revenue of USD 1910.0 Million in the year 2021. By application, the market is segmented into fungal diseases, pain management, cancer therapy, viral vaccines, photodynamic therapy, and others. The cancer therapy segment is projected to garner the largest revenue of USD 5538.8 Million by the end of 2031, up from a revenue of USD 2024.5 Million in the year 2021.

Key Companies Dominating the Market

Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global liposome drug delivery market that are included in our report are Spectrum Pharmaceuticals, Inc., Gilead Sciences, Inc., Celsion Corporation, Ipsen Pharma, Pacira Pharmaceuticals, Inc., Novartis AG, CordenPharma International, FUJIFILM Toyama Chemical Co., Ltd., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services, Inc., Astellas Pharma Inc., Elan Pharmaceuticals (Perrigo Company plc), Merrimack Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc., and others. Besides this, some of the prominent raw material manufacturers in the global liposome drug delivery market that are included in our report are NIPPON FINE CHEMICAL CO., LTD., Sonic Biochem Extractions Pvt. Ltd., Croda International Plc, Lipoid GmbH, Hashimoto Electronic Industry Co., LTD, and others.

Key Reasons to Buy Our Report

  • The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
  • It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
  • The report includes detailed company profiles of the major players dominating the market.
  • We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
  • We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.

FREQUENTLY ASKED QUESTIONS

  1. Market Definition
    1. Definition
    2. Market Segmentation
  2. Assumptions and Acronyms
  3. Research Methodology
    1. Research Process
    2. Primary Research
    3. Secondary Research
  4. Executive Summary – Global Liposome Drug Delivery Market
  5. Market Dynamics
    1. Drivers
    2. Challenges
    3. Trends
    4. Opportunities
  6. Pipeline Analysis
  7. Clinically Marketed Liposome Drugs
  8. Regulatory Scenario Assessment
  9. Analysis on Lipid Nanoparticles
  10. Competitive Landscape
    1. Market Share Analysis, 2021
    2. Company Profiles
      1. Pharmaceutical Formulation Manufacturers
        1. Spectrum Pharmaceuticals, Inc.
        2. Gilead Sciences, Inc.
        3. Celsion Corporation
        4. Ipsen Pharma
        5. Pacira Pharmaceuticals, Inc.
        6. Novartis AG
        7. CordenPharma International
        8. FUJIFILM Toyama Chemical Co., Ltd.
        9. Takeda Pharmaceutical Company Limited
        10. Johnson & Johnson Services, Inc.
        11. Astellas Pharma Inc.
        12. Elan Pharmaceuticals (Perrigo Company plc)
        13. Merrimack Pharmaceuticals, Inc.
        14. Janssen Pharmaceuticals, Inc.
      2. Raw Material Manufacturers
        1. NIPPON FINE CHEMICAL CO., LTD.
        2. Sonic Biochem Extractions Pvt. Ltd.
        3. Croda International Plc
        4. Lipoid GmbH
        5. Hashimoto Electronic Industry Co., LTD
  11. Global Liposome Drug Delivery Market
    1. Market Overview
    2. Market Size (2021-2031)
    3. Market Segmentation by:
      1. Product
        1. Liposomal Doxorubicin, 2021-2031F (USD Million)
        2. Liposomal Paclitaxel, 2021-2031F (USD Million)
        3. Liposomal Amphotericin, 2021-2031F (USD Million)
        4. Others, 2021-2031F (USD Million)
      2. Technology
        1. Stealth Liposome Technology, 2021-2031F (USD Million)
        2. Non-PEGylated Liposome Technology, 2021-2031F (USD Million)
        3. DepoFoam Liposome Technology, 2021-2031F (USD Million)
      3. Application
        1. Fungal Diseases, 2021-2031F (USD Million)
        2. Pain Management, 2021-2031F (USD Million)
        3. Cancer Therapy, 2021-2031F (USD Million)
        4. Viral Vaccines, 2021-2031F (USD Million)
        5. Photodynamic Therapy, 2021-2031F (USD Million)
        6. Others, 2021-2031F (USD Million)
      4. Region
        1. North America, 2021-2031F (USD Million)
        2. Europe, 2021-2031F (USD Million)
        3. Asia Pacific, 2021-2031F (USD Million)
        4. Latin America, 2021-2031F (USD Million)
        5. Middle East & Africa, 2021-2031F (USD Million)
  12. North America Liposome Drug Delivery Market
    1. Market Overview
    2. Market Size (2021-2031)
    3. Market Segmentation by:
      1. Product
        1. Liposomal Doxorubicin, 2021-2031F (USD Million)
        2. Liposomal Paclitaxel, 2021-2031F (USD Million)
        3. Liposomal Amphotericin, 2021-2031F (USD Million)
        4. Others, 2021-2031F (USD Million)
      2. Technology
        1. Stealth Liposome Technology, 2021-2031F (USD Million)
        2. Non-PEGylated Liposome Technology, 2021-2031F (USD Million)
        3. DepoFoam Liposome Technology, 2021-2031F (USD Million)
      3. Application
        1. Fungal Diseases, 2021-2031F (USD Million)
        2. Pain Management, 2021-2031F (USD Million)
        3. Cancer Therapy, 2021-2031F (USD Million)
        4. Viral Vaccines, 2021-2031F (USD Million)
        5. Photodynamic Therapy, 2021-2031F (USD Million)
        6. Others, 2021-2031F (USD Million)
      4. Country
        1. United States, 2021-2031F (USD Million)
        2. Canada, 2021-2031F (USD Million)
  13. Europe Liposome Drug Delivery Market
    1. Market Overview
    2. Market Size (2021-2031)
    3. Market Segmentation by:
      1. Product
      2. Technology
      3. Application
      4. Country
        1. Germany, 2021-2031F (USD Million)
        2. United Kingdom, 2021-2031F (USD Million)
        3. France, 2021-2031F (USD Million)
        4. Italy, 2021-2031F (USD Million)
        5. Spain, 2021-2031F (USD Million)
        6. Rest of Europe, 2021-2031F (USD Million)
  14. Asia Pacific Liposome Drug Delivery Market
    1. Market Overview
    2. Market Size (2021-2031)
    3. Market Segmentation by:
      1. Product
      2. Technology
      3. Application
      4. Country
        1. China, 2021-2031F (USD Million)
        2. India, 2021-2031F (USD Million)
        3. Japan, 2021-2031F (USD Million)
        4. Australia, 2021-2031F (USD Million)
        5. New Zealand, 2021-2031F (USD Million)
        6. Rest of APAC, 2021-2031F (USD Million)
  15. Latin America Liposome Drug Delivery Market
    1. Market Overview
    2. Market Size (2021-2031)
    3. Market Segmentation by:
      1. Product
      2. Technology
      3. Application
      4. Country
        1. Brazil, 2021-2031F (USD Million)
        2. Mexico, 2021-2031F (USD Million)
        3. Rest of LATAM, 2021-2031F (USD Million)
  16. Middle East & Africa Liposome Drug Delivery Market
    1. Market Overview
    2. Market Size (2021-2031)
    3. Market Segmentation by:
      1. Product
      2. Technology
      3. Application
      4. Country
        1. GCC, 2021-2031F (USD Million)
        2. South Africa, 2021-2031F (USD Million)
        3. Rest of MEA, 2021-2031F (USD Million)

Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved